RESEARCH MONOGRAPH · KDC-MN-113

Panax Ginseng

May 9, 2026 Kodiac biolabs Research Revised May 30, 2026 2 min read

Our opinion on this compound

72/100

Ginsenosides are a real molecular family with real human trials. The signal is modest but unusually well-replicated

Panax ginseng has one of the larger human trial bases of any traditional botanical, partly because Korean and Japanese research groups have been working on it systematically for decades. The Cochrane reviews on cognitive and fatigue endpoints have generally come out cautiously positive, which is unusual for an herbal in those reviews. Effect sizes are modest, but the replication across small trials is decent.

The chemistry is one of the more interesting parts. Ginsenosides are a family of triterpenoid saponins, dozens of identified species (Rg1, Rb1, Rg3, Rh1, Rh2, F1, and the de-glycosylated metabolites like compound K being among the most-studied). Different ginsenosides have different and sometimes opposing pharmacologies. Rb1 and Rg1 are roughly the "yang" pair, Rb1 tends toward sedation and immune effects, Rg1 toward stimulation and cognitive endpoints. The protopanaxadiols vs protopanaxatriols framework is a useful organizing structure. The gut microbiome conversion to compound K is significant for several of them and varies person-to-person.

Mechanistically the picture is complex. Ginsenosides hit estrogen receptors, glucocorticoid receptors, NMDA glutamate receptors, and various ion channels with reasonably defined affinities in the high-nanomolar to micromolar range. The "adaptogen" framework is loose but ginsenosides are at least real GPCR and nuclear-receptor ligands, not just hand-waving.

The trials have generally shown small improvements on cognitive endpoints (working memory, attention) in healthy and impaired populations, fatigue improvements in cancer-related fatigue cohorts, and modest erectile function improvements in small trials. None of these signals are huge but the consistency is unusual.

What we like: real molecular chemistry, large historical use base, decent (if modest) RCT replication. The Korean Red Ginseng (KRG) preparations from KGC have the most trial data behind a specific preparation.

What we dont like is the species and preparation confusion. American ginseng (P. quinquefolius) and Asian ginseng (P. ginseng) have different ginsenoside profiles. Red vs white ginseng processing changes the ginsenoside content significantly. The trials use specific preparations and generalizing across products is risky.

Sourcing: KRG or other steamed-and-dried Asian ginseng standardized to total ginsenoside content (typically 4-7%) is the reasonable choice. Pure ginsenoside Rg3, Rb1, or compound K are available for research mechanism work at high purity.

Old, well-studied, modestly active, defensible.

Evidence: 68
Mechanism: 70
Reliability: 68
Safety: 82
Sourcing: 75
Value: 70
Signal: 70
Staying power: 75

Plain-language summary Intrigue 55 / 100

Panax ginseng is the original Asian ginseng, used in traditional medicine for thousands of years. Ginsenosides drive the energy, cognitive, and stress-resistance effects. Not stocked by Kodiac. This monograph is provided for research and educational reference.

Intrigue 0–100 blends mechanism novelty, evidence strength, and translational potential. Kodiac editorial, not peer-reviewed.

Asian ginseng adaptogen

The classical Asian ginseng root with documented cognitive and metabolic effects mediated through ginsenoside saponins.

Abstract

Panax ginseng (Asian or Korean ginseng) is the most studied of the Panax genus, with millennia of traditional use in East Asian medicine. The active constituents are ginsenosides (Rg1, Rb1, Rb2, Rd, Re, Rf, and others), triterpene saponins with diverse pharmacological activities. The compound has documented modest effects on cognitive function (working memory, attention), fatigue, immune function, and erectile function. Mechanism is highly variable across ginsenosides (some are CNS stimulant-like, others sedating; some immunomodulatory, others not), making whole-extract pharmacology multifaceted. Reported research dose ranges in the literature use standardized extract (4 to 7 percent ginsenosides). The compound interacts with many drugs through CYP modulation.

Mechanism of action

Multiple ginsenoside saponins with varied pharmacology. Cholinergic, adrenergic, and immune effects.

Reported research dose ranges

Reported research dose ranges in the literature describe standardized extract quantities.

References

Geng J, et al. Ginseng for cognition. Cochrane Database Syst Rev 2010.

Read the full monograph

The full reference document covers compound identification, discovery and developmental history, mechanism of action, pharmacokinetics, reported research dose ranges, sourcing and quality verification, reconstitution and handling, stack interaction considerations, and a curated reference list. Available as a research-use-only PDF download.

KDC-MN-113

The full reference document is provided strictly for research use only. It reports research dose ranges from the published literature, not instructions for use in humans or animals.

Download PDF →

FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human consumption. All information is provided for research and educational purposes only.

Kodiac sells research compounds for investigative use only.

Panax Ginseng

Abstract

Mechanism of action

Reported research dose ranges

References

Read the full monograph

Quick actions

Categories

Help and policies

Abstract

Mechanism of action

Reported research dose ranges

References

Read the full monograph

Adjacent monographs